期刊文献+

睡眠呼吸暂停/低通气综合征患者心钠素变化及意义 被引量:6

The change and significance of atrial natriuretic peptide in the patient with sleep apnea/hypopnea syndrome
下载PDF
导出
摘要 目的 探讨睡眠呼吸暂停 /低通气综合征 (SAHS)患者心钠素 (ANP)变化及意义。方法 根据多导睡眠图检查结果 ,将 90例患者分为正常对照组、轻度SAHS组和中重度SAHS组 ,用放免法测定各组早晨 6点血浆中ANP含量 ,中重度SAHS组经鼻持续气道正压通气 (NCPAP)治疗后再次测定血浆ANP含量。结果 轻度SAHS组ANP含量明显高于对照组 ,中重度SAHS组明显高于轻度SAHS组 ,分别为 (0 173± 0 0 0 4 )、(0 2 12± 0 0 0 4 )和 (0 2 6 8± 0 0 0 3) μg/L(P <0 0 1)。经NCPAP治疗后血浆ANP含量较前明显下降 ,为 (0 2 2 3± 0 0 0 1) μg/L ,与治疗前相比有显著性差异 (P <0 0 1)。结论 SAHS患者随呼吸紊乱指数的增高 ,血浆中ANP含量明显增高 ,NCPAP治疗后明显降低 ,提示ANP检测可作为评价SAHS严重程度和治疗效果的一种简便、可靠的辅助指标。 Objective To investigate the change and significance of atrial natriuretic peptide (ANP) in the patients with sleep apnea/hypopnea syndrome (SAHS).Methods 90 subjects were divided into three groups,ie,the normal group with AHI<5,the mild SAHS group with 5≤AHI<20,and the moderate/severe SAHS group with AHI≥20.The concentrations of ANP in the plasma sampled in the morning were measured with radio-immune assay.After the treatment of nasal continuous positive airway pressure(NCPAP) the concentration of ANP in the plasma from the moderate and severe group were measured again.Results The concentration of ANP in the mild SAHS group was markedly higher than that in the normal group but markedly lower than that in the moderate/severe group [(0.173 0.004),(0.212±0.004),and (0.268±0.003)μg/L( P <0.01),respectively].After the treatment of NCPAP,the concentration of ANP was decreased apparently [(0.223±0.001) vs (0.268±0.003)μg/L,respectively, P <0.01].Conclusions As the AHI score increased in the SAHS patients,the concentrations of ANP increased markedly which decreased obviously after the treatment of NCPAP.This indicates that the measurement of ANP concentration is a simple and reliable way to evaluate the degree of SAHS and the effectiveness of NCPAP treatment.
出处 《中国呼吸与危重监护杂志》 CAS 2004年第1期43-46,共4页 Chinese Journal of Respiratory and Critical Care Medicine
关键词 睡眠呼吸暂停/低通气综合征 心钠素 多导睡眠图 放射免疫法 Sleep apnea/hypopnea syndrome Atrial natriuretic peptide Continuous positive airway pressure
  • 相关文献

参考文献24

  • 1钮善福.进一步拓宽面罩机械通气的临床适应证[J].中国呼吸与危重监护杂志,2002,1(4):197-198. 被引量:142
  • 2While DP, Gibb TJ,Wall JM,el al. Assessment of accuracy and analysis time of novel device to monilor sleep and breathing in the home. Sleep,1995; 18:115- 126.
  • 3Teschler H. Berthon-Jones M, Thompson AB. el al. Automated continuous positive airway pressure titration for obstructive sleep apnea syndrome.Am J Respir Crit Care Med. 1996; 154:734 - 740.
  • 4Duchna HW, Guilleminault C, Stoohs RA. Obstructive sleep apnea syndrome : a cardiovascular risk factor? Z Kardiol, 2001 ;90:568 - 575.
  • 5Katayanta S. Sleep apnea syndrome and hypertension. Nippon Rinsho,2000;58:571 - 578.
  • 6Maekawa M, Shiomi T. Sleep apnea syndrome and ischemic heart disease. Nippon Rinsho,2000;58: 1702- 1706.
  • 7Bonsigngnore MR, Marrone O,Insalaco G. et al. The cardiovascular effects of obstructive sleep apneas: analysis of pathogenic mechanisms. Ear Respir J, 1994 ; 7 : 786 - 805.
  • 8Tasue H,Toshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 1994 ; 90 : 195 - 203.
  • 9Cheung BM, Brown MJ. Plasama brain natriuretic peptide and C-type natriuretie peptide in essential hypertension. J Hyperten, 1994; 12 : 449 -454.
  • 10Klinger JR,Warburton RR, Pietras LA, et al. Genetit, disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxie mice, Am J Physiol, 1999 ; 276 : L868 - L874.

二级参考文献11

  • 1Schahar E,Whitney CW,Redline S,et al.Sleeping-disordered breathing and cardiovascular disease:cross-sectional results of the Sleep Heart Health Study.Am J Respir Crit Care Med,2001;163:19~25
  • 2Miller SA,Dyke DD,Polesky HF.A simple salting out procedure for extrating DNA from human nucleated cells.Nucleic Acids Res,1988;16:1215
  • 3Mooe T,Franklin KA,Wikland U,et al.Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease.Chest,2000;117:1597~1602
  • 4Koenig W.Fibrinogen and coronary risk.Curr Cardiol Rep,1999;1:112~118
  • 5von Eyben FE,Mouritsen E,Holm J,et al.Smoking,low density lipoprotein cholesterol,fibrinogen and myocardial infarction before 41 years of age:a Danish case-control study.J Cardiocasc Risk,2002;9:171~178
  • 6Vischetti M,Zito F,Donati MB,et al.Analysis of gene-environment interaction in coronary heart disease:fibrinogen polymorphisms as an example.Ital heart J,2002;3:18~23
  • 7Franco RF,Reitsma PH.Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease.Br J Haematol,2001;115:491~506
  • 8Carter AM,Catto AJ,Bamford JM,et al.Gender specific associations of the fibrinogen Bβ448 polymorphism,flbrinogen levels and acute cerebrovascular disease.Arteriostler Thromb Vasc Biol,1997;17:589~594
  • 9Kiely JL,McNicholas WT.Cardiovascular risk factors in patients with obstructive sleep apnea syndrome.Eur Respir J,2000;16:128~133
  • 10Peter Y,Hedner J,Kraiczi H.Respiratory disturbance index:an independent predictor of mortality in coronary artery disease.Am J Respir Crit Care Med,2000;162:81~86

共引文献142

同被引文献35

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部